SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Notifiable Interest

21 Feb 2012 15:38

RNS Number : 8394X
Accsys Technologies PLC
21 February 2012
 



AIM: AXS

NYSE Euronext Amsterdam: AXS

21 February 2012

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Notifiable Interest

 

The Company announces that it received the following notification on 21 February 2012

 

 

 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

ACCSYS TECHNOLOGIES

 

2. Reason for the notification  (please tick the appropriate box or boxes)

 

An acquisition or disposal of voting rights

X

 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify): ___________

 

3. Full name of person(s) subject to the notification obligation:

Ignis Investment Services Limited

 

4. Full name of shareholder(s) (if different from 3.):

 

5. Date of the transaction and date on which the threshold is crossed or reached if different:

20/02/2012

 

6. Date on which issuer notified:

21/02/2012

 

7. Threshold(s) that is/are crossed or reached:

3%

8.Notified details: Nominee holdings

 

A: Voting rights attached to shares

 

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

 

Number of Shares

Number of Voting Rights viii

Number of shares

Number of voting rights

% of voting rights

 

Direct

Direct

Indirect

Direct

Indirect

 

B0LMC53

12,745,070

3.15%

 

B: Financial Instruments

 

Resulting situation after the triggering transaction xii

 

Type of financial instrument

Expiration date

Exercise/ Conversion Period/ Date

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

 

Resulting situation after the triggering transaction

 

Type of financial instrument

Exercise price

Expiration Date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

Nominal

Delta

 

 

Total (A+B+C)

 

Number of voting rights

Percentage of voting rights

 

12,745,070.00

3.15%

 

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 

Vidacos Nominees Ltd (12,745,070.00 3.15%)

 

 

Phoenix Group Holdings

Impala Holdings Limited

Ignis Asset management Ltd

Ignis Investment Services Ltd (indirect)

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

Percentage calculation based on Issued Share Capital of 404016642

14. Contact name:

Stuart Caldwell

15. Contact telephone number:

0141 222 8158

 

ENDS

For further information, please contact:

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

 via Citigate Dewe Rogerson

 

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

 

+44 (0)20 7260 1000

 

 

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

 

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

 

Notes to Editors:

Accsys Technologies PLC(www.accsysplc.com ) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its 100% owned subsidiary, Titan Wood Limited (trading as Accsys Technologies), which has manufacturing operations in Arnhem, the Netherlands, a European office in Windsor and an American office in Dallas, Texas. Accsys Technologies PLC is listed on the London Stock Exchange AIM market, and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) the Accoya® wood production facility; (ii) technology development, focused on a programme of continuous development and improvements to the process engineering and operating protocols for the acetylation of wood which are currently under development and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

Accoya® wood (www.accoya.com ) is produced using Accsys' proprietary patented process, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and temperate hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Tricoya® Wood Elements (www.tricoya.com ) are produced using Accsys' proprietary technology for the acetylation of wood chips and particles and are used in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

For an archive of news, visit www.accoya.com/news or www.accsysplc.com/news

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUMPPUPPGAG
Date   Source Headline
8th Jun 202610:10 amRNS-RNotice of Results & Investor Presentation via IMC
21st Apr 20267:00 amRNSTrading Update
17th Apr 20267:00 amRNSAnalyst Site Visit, Arnhem, NL
7th Apr 202611:40 amRNSStandard form for notification of major holdings
30th Mar 20267:00 amRNSChange of external auditor
30th Jan 20261:30 pmRNSTotal Voting Rights
26th Jan 20267:00 amRNSStandard form for notification of major holdings
22nd Jan 20262:00 pmRNSStandard form for notification of major holdings
16th Jan 20267:00 amRNSAccsys Employee Share Plan - Issue of Shares
11th Dec 20252:00 pmRNSStandard form for notification of major holdings
11th Dec 20257:00 amRNS-RProgressive Research Initiation Note Publication
9th Dec 20254:06 pmRNSSecondary Sale in Accsys Technologies PLC Shares
25th Nov 20257:01 amRNS-RLaunch of Accsys Sustainability Plan
25th Nov 20257:00 amRNSInterim results for six months ended 30 Sep 2025
10th Nov 20257:00 amRNSNotice of Interim Results & Investor Presentation
22nd Oct 20257:00 amRNSSuccessful Completion of Debt Refinancing
24th Sep 20255:15 pmRNSResult of AGM
24th Sep 20257:00 amRNSTrading Update
21st Jul 202510:00 amRNS2025 Annual Report and Notice of AGM
14th Jul 20257:00 amRNSDirector/PDMR Shareholding
30th Jun 202512:30 pmRNSDirector/PDMR Shareholding
24th Jun 20257:00 amRNSPreliminary results for the year end 31 March 2025
5th Jun 20257:00 amRNS-RInvestor Presentation via Investor Meet Company
7th May 20257:00 amRNSTrading Update
2nd Apr 20257:00 amRNSAppointment of Nominated Advisor and Broker
27th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
24th Feb 20259:00 amRNSHolding(s) in Company
30th Jan 20257:00 amRNSInvestor Strategy Day
29th Nov 20249:00 amRNSDirector/PDMR Shareholding
27th Nov 20243:00 pmRNSDirector LTIP Award
26th Nov 20247:00 amRNSInterim results for six months ended 30 Sep 2024
6th Nov 20242:00 pmRNSNotice of Results
25th Sep 20243:00 pmRNSResult of AGM
24th Sep 20247:00 amRNSDirectorate Update
19th Sep 20247:00 amRNSHull Plant
4th Sep 20243:15 pmRNSDirector/PDMR Shareholding
4th Sep 20247:00 amRNSTrading Update
2nd Sep 20245:00 pmRNSBlock listing 6 monthly return
2nd Sep 20245:00 pmRNSTotal Voting Rights
16th Aug 20242:00 pmRNSNotice of Annual General Meeting 2024
19th Jul 20244:30 pmRNSAnnual Financial Report
19th Jul 20244:20 pmRNSDirector/PDMR Shareholding
5th Jul 20247:00 amRNSDirectorate Update
26th Jun 20247:00 amRNSPRELIMINARY RESULTS FOR THE YEAR END 31 MARCH 2024
16th May 20247:00 amRNSDirectorate Change
2nd May 20247:00 amRNSTrading Update
28th Mar 202412:00 pmRNSDirector Interests
1st Mar 20247:00 amRNSBlock listing Six Monthly return
27th Feb 20247:00 amRNSBlock listing application to AIM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.